Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BRISTOL MYERS SQUIBB CO | Director | Deferred Share Units | 27,341 | $1.33 M | $48.67 | Feb 1, 2024 | Direct |
EYENOVIA, INC. | Director | Stock Option (right to buy) | 30,769 | $185 K | $6.01 | Jun 16, 2022 | Direct |
EYENOVIA, INC. | Director | Common Stock, par value $.0001 | 30,408 | $41.4 K | $1.36 | Jun 16, 2022 | Direct |
Outlook Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 94,441 | Mar 7, 2024 | Direct |